Literature DB >> 32566937

Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.

Sailish Honap1, Polychronis Pavlidis1,2, Shuvra Ray1, Esha Sharma1, Simon Anderson1, Jeremy D Sanderson1,3, Joel Mawdsley1, Mark A Samaan1, Peter M Irving1,4.   

Abstract

Entities:  

Keywords:  JAK inhibitor; tofacitinib; ulcerative colitis

Year:  2020        PMID： 32566937     DOI： 10.1093/ibd/izaa157

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  7 in total

1.  Tofacitinib: An Option for Acute Severe Ulcerative Colitis?

Authors:  Sara Santos; Verónica Gamelas; Rita Saraiva; Guilherme Simões; Joana Saiote; Jaime Ramos
Journal:  GE Port J Gastroenterol       Date:  2021-03-08

2.  How to manage: acute severe colitis.

Authors:  Thomas Edward Conley; Joseph Fiske; Sreedhar Subramanian
Journal:  Frontline Gastroenterol       Date:  2021-02-17

3.  Tofacitinib Downregulates TNF and Poly(I:C)-Dependent MHC-II Expression in the Colonic Epithelium.

Authors:  Shreya Gopalakrishnan; Marianne Doré Hansen; Helene Kolstad Skovdahl; Ingrid Aass Roseth; Atle van Beelen Granlund; Ann Elisabet Østvik; Ingunn Bakke; Arne Kristian Sandvik; Torunn Bruland
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

Review 4.  Treatment of Inflammatory Bowel Disease: A Comprehensive Review.

Authors:  Zhaobei Cai; Shu Wang; Jiannan Li
Journal:  Front Med (Lausanne)       Date:  2021-12-20

Review 5.  Optimal Management of Acute Severe Ulcerative Colitis (ASUC): Challenges and Solutions.

Authors:  Tom Holvoet; Triana Lobaton; Pieter Hindryckx
Journal:  Clin Exp Gastroenterol       Date:  2021-03-08

6.  JAK1 inhibition and inflammatory bowel disease.

Authors:  Clare Harris; J R Fraser Cummings
Journal:  Rheumatology (Oxford)       Date:  2021-05-05       Impact factor: 7.580

Review 7.  Tofacitinib and newer JAK inhibitors in inflammatory bowel disease-where we are and where we are going.

Authors:  Eleanor Liu; Nasar Aslam; Gaurav Nigam; Jimmy K Limdi
Journal:  Drugs Context       Date:  2022-04-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.